4th Quarter - Report

THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH for THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH

Firm
Client
Income
—
Expenses
$18,500
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Support of pharmaceutical innovation Changes to The Prescription Drug User Fee Act S.475 - RxCAP Act of 2019 Support of an out-of-pocket spending cap for Medicare Part D Support for Value Based Arrangements in Medicare and Medicaid

LobbyistCovered position, as disclosed
BRITTANY MEYER Senior Associate Director, Public Policy

Contacted: SENATE; Environmental Protection Agency (EPA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Bills named: S. 475 (116th)

Environment/Superfund ENV

Environmental Protection Agency's Transparency Rule Cost / Benefit analysis

LobbyistCovered position, as disclosed
BRITTANY MEYER Senior Associate Director, Public Policy

Contacted: Food & Drug Administration (FDA); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH)

Veterans VET

Parkinsons Disease Research, Education and Clinical Centers (PADRECCs) at the Department of Veterans Affairs and the Medical Services Account H.R.663 / S. 191 - Burn Pits Accountability Act H.R. 2500- National Defense Authorization Act for Fiscal year 2020 S. 4049-National Defense Authorization Act for Fiscal Year 2021 H.R.5610- Fair Care for Vietnam Veterans Act H.Res. 729 - Encouraging the President to expand the list of the Department of Veterans Affairs of presumptive medical conditions associated with exposure to Agent Orange to include Parkinsonism, bladder cancer, hypertension, and hypothyroidism S.Amdt.1972- Expand the list of diseases associated with exposure to certain herbicide agents

LobbyistCovered position, as disclosed
BRITTANY MEYER Senior Associate Director, Public Policy

Contacted: Food & Drug Administration (FDA); Environmental Protection Agency (EPA); SENATE; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Bills named: H.R. 2500 (116th), S. 191 (116th), H.R. 5610 (116th), H.Res. 729 (116th), S. 4049 (116th), H.R. 663 (116th)

Medicare/Medicaid MMM

S.2772 - Medicare Mental Health Access Act H.R.3772- Medicare Diagnostic Radiopharmaceutical Payment Equality Act of 2019 H.R. 7078, the Evaluating Disparities and Outcomes of Telehealth During the COVID-19 Emergency Act of 2020 Medicaid non-emergency medical transportation (NEMT) S.475 - RxCAP Act of 2019 H.R. 945/S. 286, the Mental Health Access Improvement Act of 2019 Support of an out-of-pocket spending cap for Medicare Part D Support for Value Based Arrangements in Medicare and Medicaid

LobbyistCovered position, as disclosed
AARON POLACEK Associate Director, Public Policy

Contacted: Environmental Protection Agency (EPA); SENATE; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Food & Drug Administration (FDA)

Bills named: H.R. 3772 (116th), H.R. 945 (116th), S. 286 (116th), S. 475 (116th), S. 2772 (116th), H.R. 7078 (116th)

Budget/Appropriations BUD

Parkinsons Disease Research, Education and Clinical Centers (PADRECCs) at the Department of Veterans Affairs and the Medical Services Account Federal appropriations for National Institutes of Health and the Centers for Disease Control; Federal appropriations for Department of Defense Medical Research Programs Federal appropriations for Food and Drug Administration Federal appropriations for Department of Defense Medical Research Programs The Coronavirus Aid, Relief, and Economic Security Act (CARES)

LobbyistCovered position, as disclosed
BRITTANY MEYER Senior Associate Director, Public Policy

Contacted: Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Extension of threshold for medical expense deduction H.R.3797- Medical Marijuana Research Act S.2032- Cannabidiol and Marihuana Research Expansion Act H.R. 7663- Protecting Access to Post-COVID-19 Telehealth Act of 2020 H.R.7078, the Evaluating Disparities and Outcomes of Telehealth During the COVID-19 Emergency Act of 2020 Expand eligibility for paid family and medical leave for high-risk individuals during the pandemic Telehealth guidelines for making the flexibilities permanent Medicaid non-emergency medical transportation (NEMT) Improving Seniors Timely Access to Care Act (H.R. 3107) S. 1384, the Prescription Drug Rebate Reform Act of 2019 S.475 - RxCAP Act of 2019 H.R. 945/S. 286, the Mental Health Access Improvement Act of 2019 H.R. 601 - Medical Cannabis Research Act of 2019 Support of an out-of-pocket spending cap for Medicare Part D Support for Value Based Arrangements in Medicare and Medicaid Coronavirus Aid, Relief, and Economic Security Act General information about Parkinson's disease, the need for research funding, and protecting access to care

LobbyistCovered position, as disclosed
AARON POLACEK New Public Policy Officer

Contacted: Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 7078 (116th), H.R. 601 (116th), H.R. 945 (116th), H.R. 7663 (116th), S. 475 (116th), H.R. 3107 (116th), S. 2032 (116th), H.R. 3797 (116th), S. 286 (116th), S. 1384 (116th)

Agriculture AGR

Environmental agitators of Parkinson's disease HR 7940 / S 4406 Protect Americas Children from Toxic Pesticides Act HR 230 Ban Toxic Pesticides Act of 2019 HR 3817 Protect Against Paraquat Act

LobbyistCovered position, as disclosed
BRITTANY MEYER Senior Associate Director, Public Policy

Contacted: Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Natl Institutes of Health (NIH)

Bills named: H.R. 7940 (116th), H.R. 3817 (116th), H.R. 230 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.